Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Heger-Mahn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Discussion on early clinical drug development in the target population with respect to the field of reproductive endocrinologyC Klipping, D Heger-Mahn
Journal of the American Academy of Dermatology|October 1, 1993
Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activityA Kecskés, D Heger-Mahn, R K Kuhlmann, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 9, 2005
Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteersD Heger-Mahn, C Warlimont, T Faustmann, et al.
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|September 1, 1995
A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptiveA Heuner, W Kuhnz, D Heger-Mahn, et al.
Contraception|November 5, 1997
Short-term treatment with levonorgestrel does not antagonize the ethinyl estradiol-induced increase of uterine blood flow in postmenopausal womenM Entezami, D Heger-Mahn, A Ebert, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1996
[Estrogenic effects after 14-days administration of 0.06 mg ethinyl estradiol in postmenopausal women]D Heger-Mahn, M Entezami, B Schütt, et al.
Arzneimittel-Forschung|March 1, 1995
[Dealing with adverse effects in phase I trials]D Heger-Mahn, M Mahler, R Hermann, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Adverse events and discomfort in studies on healthy subjects: the volunteer's perspective. A survey conducted by the German Association for Applied Human PharmacologyR Hermann, D Heger-Mahn, M Mahler, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Discussion on early clinical drug development in the target population with respect to the field of reproductive endocrinologyC Klipping, D Heger-Mahn
Journal of the American Academy of Dermatology|October 1, 1993
Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activityA Kecskés, D Heger-Mahn, R K Kuhlmann, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 9, 2005
Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteersD Heger-Mahn, C Warlimont, T Faustmann, et al.
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|September 1, 1995
A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptiveA Heuner, W Kuhnz, D Heger-Mahn, et al.
Contraception|November 5, 1997
Short-term treatment with levonorgestrel does not antagonize the ethinyl estradiol-induced increase of uterine blood flow in postmenopausal womenM Entezami, D Heger-Mahn, A Ebert, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1996
[Estrogenic effects after 14-days administration of 0.06 mg ethinyl estradiol in postmenopausal women]D Heger-Mahn, M Entezami, B Schütt, et al.
Arzneimittel-Forschung|March 1, 1995
[Dealing with adverse effects in phase I trials]D Heger-Mahn, M Mahler, R Hermann, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Adverse events and discomfort in studies on healthy subjects: the volunteer's perspective. A survey conducted by the German Association for Applied Human PharmacologyR Hermann, D Heger-Mahn, M Mahler, et al.
Pageof 1